Read more
http://news.bms.com/press-release/arthritis/european-commission-approves-bristol-myers-squibbs-orencia-abatacept-treatme
Bristol-Myers Squibb’s
Selected Products list
ATRIPLA® (efavirenz/emtricitabine/tenofovir disoproxil fumarate)
Prescribing Information including Boxed WARNINGS
Patient Information
Product Website
AZACTAM® (aztreonam injection) in GALAXY Plastic Container
Prescribing Information
AZACTAM® (aztreonam for injection, USP)
Prescribing Information
BARACLUDE® (entecavir)
Prescribing Information including Boxed WARNINGS
Patient Information
Product Website
COUMADIN® (warfarin sodium)
Prescribing Information including Boxed WARNING
Medication Guide
Product Website
DAKLINZA™ (daclatasvir)
Prescribing Information
Patient Information
Product Website
DROXIA® (hydroxyurea)
Prescribing Information including Boxed WARNING
ELIQUIS® (apixaban)
Prescribing Information including Boxed WARNING
Medication Guide
Product Website
EMPLICITI™ (elotuzumab)
Prescribing Information
Patient Information
ETOPOPHOS® (etoposide phosphate)
Prescribing Information including Boxed WARNINGS
EVOTAZ™ (atazanavir and cobicistat)
Prescribing Information
Patient Information
Product Website
GLUCOPHAGE® (metformin hydrochloride)
Prescribing Information
GLUCOPHAGE® XR (metformin hydrochloride) EXTENDED RELEASE
Prescribing Information
GLUCOVANCE® (glyburide and metformin hydrochloride)
Prescribing Information
HYDREA® (hydroxyurea)
Prescribing Information
KENALOG®-10 (triamcinolone acetonide)
Prescribing Information
KENALOG®-40 (triamcinolone acetonide)
Prescribing Information
LYSODREN® (mitotane)
Prescribing Information including Boxed WARNINGS
MEGACE® (megestrol acetate)
Prescribing Information
NULOJIX® (belatacept)
Prescribing Information including Boxed WARNINGS
Medication Guide
REMS Materials
Product Website
OPDIVO® (nivolumab)
Prescribing Information
Medication Guide
Product Website
ORENCIA® (abatacept)
Prescribing Information
Patient Information
Instructions for Use
Product Website
PLAVIX® (clopidogrel bisulfate)
Prescribing Information including Boxed WARNING
Medication Guide
PRAVACHOL® (pravastatin sodium)
Prescribing Information
REYATAZ® (atazanavir)
Prescribing Information
Patient Information
Instructions for Use
Product Website
SPRYCEL® (dasatinib)
Prescribing Information
Patient Information
Product Website
SUSTIVA® (efavirenz)
Prescribing Information
Patient Information
Instructions for Use
SUSTIVA Capsule Instructions for Use Video
Product Website
VIDEX® (didanosine)
Prescribing Information including Boxed WARNINGS
Medication Guide
VIDEX® EC (didanosine) DELAYED RELEASE
Prescribing Information including Boxed WARNINGS
Medication Guide
YERVOY® (ipilimumab)
Prescribing Information including Boxed WARNING
Medication Guide
Product Website
ZERIT® (stavudine)
Prescribing Information including Boxed WARNING
Medication Guide
http://www.bms.com/products/Pages/home.aspx
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) will host a teleconference on Sunday, October 9, 2016, at 7:30 p.m. CEST (1:30 p.m. EDT) to discuss data presented at the European Society of Medical Oncology (ESMO) 2016 Congress in Copenhagen, Denmark. Company executives will provide an overview of data presented at the meeting, with a focus on the company’s Immuno-Oncology portfolio, and address inquiries from investors and analysts.
http://news.bms.com/press-release/financial-news/bristol-myers-squibb-hold-investor-teleconference-discuss-esmo-2016-con
Link to listen
http://investors.bms.com/investors/news-and-events/events-and-presentations/event-details/2016/ESMO-Investor-Event-2016/default.aspx
1c
Recent BMY News
- New Long-Term Zeposia (ozanimod) Data Demonstrate Durable Efficacy and Consistent Safety in Relapsing Forms of Multiple Sclerosis • Business Wire • 09/18/2024 10:59:00 AM
- Bristol Myers Squibb Presents Landmark 10-Year Follow-Up Data from CheckMate -067 Which Showed Continued Durable Long-Term Survival Benefit with Opdivo® plus Yervoy® in Advanced Melanoma • Business Wire • 09/15/2024 12:55:00 PM
- Bristol Myers Squibb to Report Results for Third Quarter 2024 on October 31, 2024 • Business Wire • 09/12/2024 10:59:00 AM
- Bristol Myers Squibb Announces Dividend • Business Wire • 09/10/2024 09:45:00 PM
- Bristol Myers Squibb to Present Data at ESMO Demonstrating Ongoing Leadership in Immuno-Oncology and Progression of Assets from Its Differentiated Research Platforms • Business Wire • 09/09/2024 10:59:00 AM
- Bristol Myers Squibb Employees to Relay Nearly 3,000 Miles Cross-Country Aspiring to Raise Over $1 Million for the V Foundation for Cancer Research • Business Wire • 09/06/2024 11:00:00 AM
- Long-Term Follow-Up Data from Phase 3 Study of CAMZYOS® (mavacamten) Underscores Established Efficacy and Safety Profile in Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) • Business Wire • 09/01/2024 07:33:00 AM
- Bristol Myers Squibb to Participate in Upcoming Investor Conferences • Business Wire • 08/27/2024 10:59:00 AM
- Bristol Myers Squibb to Present Data Across Cardiovascular Portfolio at the European Society of Cardiology Congress 2024 • Business Wire • 08/26/2024 10:59:00 AM
- Cruise and Uber Join Forces for Robotaxis, Alibaba Shifts Primary Listing to Hong Kong, Altria Hikes Dividend 4.1% • IH Market News • 08/23/2024 12:20:26 PM
- Bristol Myers Squibb Receives U.S. Food and Drug Administration sBLA Acceptance for First-Line Treatment of Unresectable Hepatocellular Carcinoma • Business Wire • 08/21/2024 10:59:00 AM
- European Medicines Agency Validates Bristol Myers Squibb’s Application for CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma • Business Wire • 08/19/2024 10:59:00 AM
- Toyota Reports Another Global Production Decline, Delta Sues CrowdStrike, Meta Launches AI Studio for Custom Chatbots • IH Market News • 07/30/2024 10:00:51 AM
- Bristol Myers Squibb Reports Second Quarter Financial Results for 2024 • Business Wire • 07/26/2024 10:59:00 AM
- U.S. Index Futures Point to Higher Open, Oil Prices Down • IH Market News • 07/26/2024 10:08:50 AM
- Dexcom Shares Drop 37% on Weak Revenue and Forecast; Coursera Rises 24% After Beating Q2 Revenue Estimates • IH Market News • 07/26/2024 09:57:38 AM
- Bristol Myers Squibb Receives European Medicines Agency Validation of Application for Opdivo (nivolumab) plus Yervoy (ipilimumab) for First-Line Treatment of Unresectable or Advanced Hepatocellular Carcinoma • Business Wire • 07/19/2024 10:59:00 AM
- Bristol Myers Squibb to Participate in UBS Virtual Targeted Protein Degradation Day • Business Wire • 07/08/2024 10:59:00 AM
- Bristol Myers Squibb Announces U.S. FDA Accelerated Approval of KRAZATI® (adagrasib) in Combination with Cetuximab for Adult Patients with Previously Treated KRAS G12C-Mutated Locally Advanced or Metastatic Colorectal Cancer (CRC) • Business Wire • 06/21/2024 11:30:00 PM
- European Medicines Agency Validates Bristol Myers Squibb’s Application for Subcutaneous Nivolumab • Business Wire • 06/21/2024 10:59:00 AM
- Bristol Myers Squibb to Report Results for Second Quarter 2024 on July 26, 2024 • Business Wire • 06/20/2024 10:59:00 AM
- Bristol Myers Squibb Elects Michael R. McMullen to Board of Directors • Business Wire • 06/18/2024 08:16:00 PM
- Bristol Myers Squibb Announces Dividend • Business Wire • 06/18/2024 10:59:00 AM
- U.S. Food and Drug Administration Approves Augtyro™ (repotrectinib), a Next-Generation Tyrosine Kinase Inhibitor (TKI), for the Treatment of Patients with NTRK-Positive Locally Advanced or Metastatic Solid Tumors • Business Wire • 06/13/2024 08:46:00 PM
- Bristol Myers Squibb Announces Opdivo (nivolumab) Plus Yervoy (ipilimumab) Significantly Improved Overall Survival Compared to Lenvatinib or Sorafenib as First-Line Treatment for Patients with Advanced Hepatocellular Carcinoma in CheckMate -9DW Trial • Business Wire • 06/04/2024 12:00:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM